IGF1 and depressive symptom measurement: Specifically, a one-point increase in the IGF-1 Z-score is associated with a 29.85% decrease in anxiety symptoms on the GAD-7, a 16.30% reduction in depression severity on the PHQ-9, and a 39.23% decrease in post-TBI symptom severity on the RPQ-13.